SCHEMBL5394355

SCHEMBL5394355

CCc1nc(OC)c(NC(=O)N2CCN(c3cc(F)cc(F)c3)CC2)cc1C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.42
KDM4E B2RXH2 2/20 0.42
HCAR2 Q8TDS4 6/20 0.41
ALDH1A1 P00352 2/20 0.40
RBP4 P02753 1/20 0.40
KMT2A Q03164 3/20 0.38
MAPK1 P28482 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GAA P10253 1/20 0.38
HSD17B10 Q99714 2/20 0.38
LMNA P02545 2/20 0.38
TP53 P04637 2/20 0.38
USP2 O75604 1/20 0.38
POLB P06746 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
PKM P14618 1/20 0.37
HTR1A P08908 1/20 0.37
HTR1D P28221 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5390177 0.91 GAA (0.46) MAPTKDM4EHCAR2ALDH1A1RBP4
SCHEMBL5390083 0.89 HCAR2 (0.41) MAPTKDM4EHCAR2ALDH1A1RBP4
SCHEMBL5399068 0.89 RBP4 (0.47) MAPTHCAR2ALDH1A1RBP4KMT2A
SCHEMBL5393937 0.89 HCAR2 (0.46) MAPTHCAR2ALDH1A1RBP4KMT2A
SCHEMBL5398654 0.88 RBP4 (0.53) MAPTKDM4EHCAR2ALDH1A1RBP4
SCHEMBL5394042 0.88 RBP4 (0.43) MAPTKDM4EHCAR2ALDH1A1RBP4
SCHEMBL5396710 0.84 HCAR2 (0.48) MAPTKDM4EHCAR2ALDH1A1RBP4
SCHEMBL8699306 0.83 MAPT (0.42) MAPTKDM4EALDH1A1RBP4KMT2A
SCHEMBL6650199 0.83 ALDH1A1 (0.51) MAPTKDM4EALDH1A1KMT2AL3MBTL1
SCHEMBL5402705 0.82 HCAR2 (0.45) MAPTHCAR2ALDH1A1RBP4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230105-B2 9-aminoacridine derivatives and process for the preparation thereof SAMJIN PHARMACEUTICAL CO., LTD. (KR) 2007-06-12 US disclosed
US-20050222167-A1 9-aminoacridine derivatives and process for the preparation thereof SAMJIN PHARMACEUTICAL CO., LTD. (KR) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222167-A1 9-aminoacridine derivatives and process for the preparation thereof PARP9, CASP9, AMPD2 MAPT 3933/4885KDM4E 2185/4885HCAR2 3647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.